… intensive courses of inflammatory bowel disease (IBD), the quality of life is impaired due
to disease-related factors that influence the health related quality of life (HRQoL) [1]. As with …

… Worldwide approximately 4 million people have inflammatory bowel disease (IBD) and
one million are in the United States [1]. The prevalence of CD and UC in children less than 20 …

… Azathioprine (AZA) is a well-known immunosuppressant used for many years for its ability
to ensure long term disease remission in inflammatory bowel diseases (IBD) at an affordable …

… CT findings were unclear in a patient with clear clinical suspicion of small bowel disease.
If the CT was positive for small bowel disease, we did not perform further radiological studies. …

… The inability to reach recruitment targets and complete trials has serious implications for
stakeholders in the inflammatory bowel disease (IBD) community. Action is required to ensure …

… Perceived quality of care in a large cohort of Italian patients with inflammatory bowel disease
remains unchanged after one-year follow-up and was not significantly affected by disease …

… /kg of body weight of TNBS in ethanol, 50% solution). For 3 days the rats were housed …
bowel disease model. The animals of each group received orally either 0.5 ml of rolipram solution …

… reduction of ditelluride 21 (75 mg, 0.3 mmol) to a colorless solution of the tellurol 18 at room
temperature, the [ll-125I]-l,ll-diiodo1-undecene ([125I] 19; 2.69 mCi) was added in EtOH, and …

… as solution or as NP formulation (PLGA or P-4135F). NP suspension or 0.1 ml of tacrolimus
solution were administered once daily for 12 continuous days (tacrolimus solution: 1 mg/kg of …

… The final diagnosis of the 33 patients was Crohn disease in 14 cases, but no small-bowel
disease was found in 16 cases. In the remaining three cases, the final diagnosis was cancer of …